Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in
WDNAWisdomTreeACTIVE

WisdomTree BioRevolution Fund

$21.84-3.23% vs prior close
16.102552-WK

Price through Nov 16, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

WDNA price

Source: Market tape, daily closes; price return, distributions not reinvested
Table
DateWDNA close
Oct 16, 2026$22.30
Oct 19, 2026$22.69
Oct 20, 2026$23.37
Oct 21, 2026$23.52
Oct 22, 2026$23.18
Oct 23, 2026$23.04
Oct 26, 2026$23.18
Oct 27, 2026$23.96
Oct 28, 2026$24.61
Oct 29, 2026$24.67
Oct 30, 2026$24.11
Nov 2, 2026$23.61
Nov 3, 2026$23.89
Nov 4, 2026$24.28
Nov 5, 2026$22.77
Nov 6, 2026$23.09
Nov 9, 2026$23.91
Nov 10, 2026$23.48
Nov 11, 2026$23.57
Nov 12, 2026$22.79
Nov 13, 2026$22.57
Nov 16, 2026$21.84

The desk’s read

Recent fund-flow records are unavailable, while the price has returned +29.4% so far this year. At 0.45% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.

COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH

$3Massets under management
0.45%expense ratio · $45 per $10,000 a year
—net flow, trailing month
2Kavg daily volume, 30 days
99holdings · US-domiciled
2021listed June 3, 2021 · beta 1.12
The book at a glance
LLY-0.8%TEM-9.6%MRNA-3.6%IMNM-6.2%TWST-5.9%TMO-1.3%STOK-0.2%UTHR-0.6%NTRA-9.6%CGON+14.0%VRTX-0.2%AMGN-0.7%GILD-0.3%TXG-5.5%ROIV-2.3%DAR-4.1%VYLR-1.0%PFE-0.1%RVMD-3.1%XNCR-4.6%KRYS-2.4%ORKA-5.8%DYN-2.7%BBIO-1.2%CRSP-4.4%PRAX-5.4%PRME-1.9%BEAM-8.3%EXEL-2.8%AGIO-4.6%BHVN-0.1%QURE-8.1%ARGX-0.9%GPCR-7.2%PTGX-4.7%FDMT-7.7%BIIB-0.7%VIR-3.8%

CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS

Holdings
#HoldingWeightPriceDay52-wk
1LLYELI LILLY3.64%$1431.67-0.8%
2TEMTEMPUS AI INC3.74%$64.76-9.6%
3MRNAMODERNA3.38%$215.27-3.6%
4IMNMIMMUNOME2.92%$17.61-6.2%
5TWSTTWIST BIOSCIENCE3.00%$105.04-5.9%
6TMOTHERMO FISHER SCIENTIFIC2.56%$691.33-1.3%
7STOKSTOKE THERAPEUTICS2.33%$26.63-0.2%
8UTHRUNITED THERAPEUTICS2.14%$587.88-0.6%
9NTRANATERA2.38%$288.48-9.6%
10CGONCG ONCOLOGY INC1.78%$84.78+14.0%
11VRTXVERTEX PHARMACEUTICALS1.90%$537.79-0.2%
12AMGNAMGEN1.81%$462.32-0.7%
13GILDGILEAD SCIENCES1.81%$167.58-0.3%
14TXG10X GENOMICS1.92%$54.99-5.5%
15ROIVROIVANT SCIENCES1.75%$38.61-2.3%

The full book, free with one sign-in.

Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.

Sign in to see all 99

Sector weights

  • Healthcare93.1%
  • Health Technology80.24%
  • Process Industries11.92%
  • Other4.81%
  • Basic Materials3.55%
  • Health Services3.18%
  • Consumer Non-Durables2.58%
  • 2.49%
  • Consumer Defensive1.77%
  • Financial Services1.58%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
Healthcare93.1%
Health Technology80.24%
Process Industries11.92%
Other4.81%
Basic Materials3.55%
Health Services3.18%
Consumer Non-Durables2.58%
2.49%
Consumer Defensive1.77%
Financial Services1.58%

Country weights

  • United States86.3%
  • Other5.19%
  • United Kingdom4.62%
  • Switzerland2.59%
  • Germany2.09%
  • Denmark2.04%
  • Japan1.4%
  • Netherlands1.18%
Source: Portfolio composition, latest disclosure
Show as table
ItemValue (%)
United States86.3%
Other5.19%
United Kingdom4.62%
Switzerland2.59%
Germany2.09%
Denmark2.04%
Japan1.4%
Netherlands1.18%
Performance
1 week-7.0%
1 month-2.1%
3 months+3.4%
6 months+26.4%
YTD+29.4%
1 year—
3 years—

PRICE RETURN, DISTRIBUTIONS NOT REINVESTED

Net flows
1 week—
1 month—
3 months—
YTD—
1 year—

CREATION/REDEMPTION DOLLARS, DAILY RECORDS

The risk read
41%realized volatility, 30 days (annualized)
30%realized volatility, 1 year
-11.7%deepest fall from a peak, 1 year
-11.5%latest close versus that peak

The top holding is 3.7% of the book; the top ten carry 28%. Spread across 83+ names, it behaves like roughly 60 equally-weighted positions.

VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK

Options tape
—calls · latest snapshot
—puts · latest snapshot
—put/call ratio
5Kshares traded
Most-traded holdings, options premiumBullishBearish
LLY ELI LILLY$43M$45M
MRNA MODERNA$30M$26M
NTRA NATERA$20M$1M
MRK MERCK & CO$6M$5M
CGON CG ONCOLOGY INC$3M$6M

TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES

The case against WDNA

Due diligence cuts both ways. These funds sit on the same shelf and beat WDNA on at least one dimension that matters — the fee, the asset base, or where the money is going.

FundFeeAssetsFlow, 1MThe case
SPDW SPDR Portfolio Developed World ex-US ETF0.03%$41.6B+$917M-42bp on fee · 16431× the assets · +$917M in over the monthHead-to-head
SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF0.03%$18.4B+$199M-42bp on fee · 7240× the assets · +$199M in over the monthHead-to-head
IJH iShares Core S&P Mid-Cap ETF0.05%$123.7B+$109M-40bp on fee · 48808× the assets · +$109M in over the monthHead-to-head
IDEV iShares Core MSCI International Developed Markets ETF0.04%$34B+$587M-41bp on fee · 13417× the assets · +$587M in over the monthHead-to-head
IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF0.04%$23.7B+$422M-41bp on fee · 9365× the assets · +$422M in over the monthHead-to-head
Sign in to save this to The RecordA timestamped copy for the file — documentation, not advice.

Watch & listen: WisdomTree

From the manager behind WDNAAll of Watch & Listen
ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.